Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gufic Biosciences has announced the closure of its trading window starting January 1, 2026, as required under SEBI's insider trading rules. The trading window will remain closed for all designated persons and their immediate relatives until 48 hours after the company announces its unaudited financial results for the quarter and nine months ended December 31, 2025. The board meeting date to approve these Q3 and 9M FY26 results has not yet been disclosed and will be communicated separately. This is a standard compliance procedure followed by listed companies ahead of earnings announcements to prevent insider trading.
This is a routine regulatory filing and does not have any direct impact on shareholders or stock price. However, it signals that the company's Q3 FY26 earnings results are expected soon, which investors should watch for as they could influence the stock.